Transcriptional profiling has been used to classify SCLC into high-NE (ASCL1 and/or NEUROD1 +) and low-NE (POU2F3 and/or Inflamed) states [2, 3]. The gene discussed is ASCL1; the disease is small cell lung carcinoma.